draft banner


M. Ryan Collins, CEO

Mr. Collins is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as CEO. Mr. Collins was previously the Vice-President of Finance for DAVA Pharmaceuticals. Prior to joining DAVA, Mr. Collins served as the Assistant Controller for Anda, Inc., the distribution division of Andrx Pharmaceuticals, and also previously served as a valuation consultant for Arthur Andersen LLP. Mr. Collins holds a Master's degree in Business Administration from the University of Florida.

Patrick Chu, President

Mr. Chu is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as President. Mr. Chu was previously the Director of Business Development and Associate General Counsel for DAVA Pharmaceuticals. Prior to joining DAVA, Mr. Chu worked at Wyeth and was also previously an associate at the law firm of Skadden Arps. Mr. Chu holds a law degree from Harvard Law School.

Stephen Richardson, Chief Scientific Officer

Mr. Richardson is responsible for all product development, regulatory, manufacturing and operations at Edenbridge Pharmaceuticals. Mr. Richardson has over 30 years of experience in the pharmaceutical industry. Prior to joining Edenbridge Mr. Richardson was the Chief Scientific Officer at Teligent Inc. and also previously served as a Principal Consultant at Lachman Consultants and VP of Scientific & Regulatory Affairs at JHP Pharmaceuticals. Mr Richardson has also held senior management roles at Stiefel Laboratories and Mayne Pharma. Mr. Richardson holds a B.S. in Chemistry and Microbiology from the University of South Australia and an MBA from Adelaide University in Australia.

Peter M. Licata, CPA, Chief Financial Officer

Mr. Licata is responsible for all accounting and finance related functions at Edenbridge Pharmaceuticals. Prior to joining the Company, Mr. Licata was the Senior Vice President of Finance at Rising Pharmaceuticals. Mr. Licata holds a bachelor's degree in accounting from the State University of New York at New Paltz and is a licensed CPA in the State of New York.

Victor Borelli, Senior Vice President, Sales & Marketing

Mr. Borelli has over 25 years of leadership experience in sales & marketing, well established customer relationships and a deep understanding of the generic pharmaceutical marketplace. Prior to joining Edenbridge, Mr. Borelli held the role of Vice President of Sales at Dr. Reddy's Laboratories and led that organization to become a top 10 supplier in the generic industry. Mr. Borelli holds a B.S. degree from Northeastern University.

Venkatesh Naini, Ph.D., Senior Vice President, Scientific Affairs

Dr. Naini is responsible for all internal product development, technical transfers and regulatory submissions at Edenbridge Pharmaceuticals. Dr. Naini has over 22 years of experience in generic pharmaceutical development and product launches. Prior to joining Edenbridge, Dr. Naini worked at several leading pharmaceutical companies including Barr, Teva, Sandoz and Aurobindo. Dr. Naini received his Ph.D. in pharmaceutics from Virginia Commonwealth University.